» Authors » P Narciso

P Narciso

Explore the profile of P Narciso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 790
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mencarini P, Bellagamba R, Oliva A, Ghirga P, Giancola M, Corpolongo A, et al.
Respir Med Case Rep . 2016 Oct; 19:150-154. PMID: 27752465
The diagnosis of sarcoidosis in a patient living with HIV infection is an uncommon event and a challenge for clinicians. Clinical manifestations are variable and fluctuating depending to adherence to...
2.
Palombi L, Mancinelli S, Liotta G, Narciso P, Marazzi M
AIDS Care . 2015 Dec; 9(6):671-80. PMID: 26665914
The aim of the paper is to examine the influence of socio-economic conditions, mental health and functional status on survival of a sample of people with AIDS. It is a...
3.
DAmato G, Liccardi G, Salzillo A, Russo M, Narciso P, Allegra L
Eur Ann Allergy Clin Immunol . 2012 Jul; 44(2):83-5. PMID: 22768728
Nasal filters (Sanispira) might represent a novel approach in preventing exacerbations of symptoms of seasonal allergic rhinitis by reducing pollen access to nasal cavities. Female and male voluntary patients between...
4.
Santoro M, Armenia D, Fabeni L, Santoro M, Gori C, Forbici F, et al.
Clin Microbiol Infect . 2012 Jun; 18(8):E289-98. PMID: 22681969
Through this study we evaluated whether the HIV-1 tropism determined by genotypic analysis correlates with HIV-1 markers, such as CD4 cell count and plasma HIV-RNA. The analysis was performed on...
5.
Massella M, Ivanovic J, Bellagamba R, De Vita R, Fracasso L, Tozzi V, et al.
Patient Prefer Adherence . 2011 Jun; 5:223-8. PMID: 21660104
This study aims to assess direct cost of reconstructive interventions with facial fillers for treatment of HIV (human immunodeficiency virus)-associated facial lipoatrophy (FLA). Evaluation was performed on data from patients...
6.
Abbate I, Rozera G, Tommasi C, Bruselles A, Bartolini B, Chillemi G, et al.
Clin Microbiol Infect . 2010 Aug; 17(5):725-31. PMID: 20731681
UDPS combined with genotypic algorithms for prediction of HIV-1 co-receptor usage may provide quantitative data about the tropism of each variant present in the viral quasispecies. The aim of the...
7.
Prosperi M, Cozzi-Lepri A, Castagna A, Mussini C, Murri R, Giacometti A, et al.
Clin Infect Dis . 2010 Mar; 50(9):1316-21. PMID: 20297953
The incidence of and predictors of acquired immunodeficiency syndrome-defining malignancies (ADMs) and non-ADM (NADMs) were evaluated in a large Italian cohort. The incidence of ADM and NADM was 5.0 cases...
8.
Nisii C, Carletti F, Castilletti C, Bordi L, Meschi S, Selleri M, et al.
Euro Surveill . 2010 Feb; 15(7). PMID: 20184855
In October 2009, a traveller returning from Africa to Italy was hospitalised with symptoms suggestive of a haemorrhagic fever of unknown origin. The patient was immediately placed in a special...
9.
Bellino S, Francavilla V, Longo O, Tripiciano A, Paniccia G, Arancio A, et al.
Rev Recent Clin Trials . 2009 Dec; 4(3):195-204. PMID: 20028332
The native HIV-1 Tat protein was chosen as vaccine candidate for phase I clinical trials in both uninfected (ClinicalTrials.gov identifier: NCT00529698) and infected volunteers (ClinicalTrials.gov identifier: NCT00505401). The rationale was...
10.
Bucciardini R, Massella M, Corpolongo A, Narciso P, Fragola V, Mirra M, et al.
Biologics . 2009 Aug; 2(3):577-81. PMID: 19707388
Aim: To evaluate the impact of health-related quality of life (HRQoL) enfuvirtide-based (ENF-based) salvage regimens of treatment-experienced HIV patients, in an observational multicenter cohort study. Methods: HRQoL was measured in...